Hydroxychloroquine or Diltiazem-Niclosamide for the Treatment of COVID-19

NCT04372082 · clinicaltrials.gov ↗

PHASE3

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped evidence showed chloroquine is not effective against COVID-19

Conditions

Sars-CoV2

Interventions

OTHER: Standard of care (SOC)
DRUG: Hydroxychloroquine
DRUG: Association of diltiazem and niclosamide

Sponsor

University Hospital, Lille

Collaborators

[object Object]